Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data

Despite the impressive impact of PD-1 (programmed cell death protein 1)-targeted cancer immunotherapy, a great part of patients with cancer fail to respond. PD-1 impact on immune cells in addition to T cells, and the synergistic role of PD-1 with other immune modulators remain largely unknown. To fi...

Full description

Bibliographic Details
Main Authors:	Qiang Liu, Ran Cheng, Xiangyi Kong, Zhongzhao Wang, Yi Fang, Jing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Immunology
Subjects:	breast cancer cancer immunotherapy PD-1 immune response inflammatory activity
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.558757/full

Similar Items

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
by: Yihang Qi, et al.
Published: (2021-06-01)

Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis
by: Yasser Tabana, et al.
Published: (2021-03-01)

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
by: Qiang Liu, et al.
Published: (2021-06-01)

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
by: Bogang Wu, et al.
Published: (2018-11-01)

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
by: Gabrielle Planes-Laine, et al.
Published: (2019-07-01)

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer
by: Cui Jiang, et al.
Published: (2019-09-01)

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
by: Qiang Liu, et al.
Published: (2020-06-01)

Cancer immunotherapies targeting the PD-1 signaling pathway
by: Yoshiko Iwai, et al.
Published: (2017-04-01)

Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients
by: Fang J, et al.
Published: (2018-08-01)

Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
by: Sebastian Chrétien, et al.
Published: (2019-05-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
by: Kübra KAHVECİ, et al.
Published: (2019-12-01)

Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
by: Daixi Ren, et al.
Published: (2020-01-01)

Progress in Clinical Researches of PD-1/PD-L1 Checkpoint Inhibitor for  Non-small Cell Lung Cancer
by: Sixuan WU, et al.
Published: (2019-07-01)

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer
by: Zi-Qi Zhou, et al.
Published: (2019-08-01)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
by: François Bertucci, et al.
Published: (2021-01-01)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
by: Vida Vafaizadeh, et al.
Published: (2020-03-01)

Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
by: Xi Chen, et al.
Published: (2020-05-01)

PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy
by: Long Jia, et al.
Published: (2018-06-01)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
by: Fei Tang, et al.
Published: (2018-05-01)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4<sup>+</sup> T Cells
by: Reem Saleh, et al.
Published: (2019-10-01)

Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy
by: Yihang Qi, et al.
Published: (2021-01-01)

A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy
by: Isaac Kim, et al.
Published: (2021-06-01)

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer
by: Ahmed A. Mostafa, et al.
Published: (2018-06-01)

Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications
by: Maria Vittoria Dieci, et al.
Published: (2021-01-01)

A novel MDSC-induced PD-1−PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties
by: Meng Shen, et al.
Published: (2018-04-01)

mRNA EXPRESSION OF PD-1, PD-L1, AND IMMUNOTHERAPY IN BLADDER CANCER
by: Muhammad Puteh Mauny, et al.
Published: (2021-07-01)

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure
by: Ranjan Pathak, et al.
Published: (2020-12-01)

Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis
by: Jue Zhu, et al.
Published: (2021-08-01)

Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer
by: Qiang Liu, et al.
Published: (2021-04-01)

Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells
by: Hadia Farrukh, et al.
Published: (2021-05-01)

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
by: Ana Bocanegra, et al.
Published: (2019-04-01)

Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
by: Mina LA, et al.
Published: (2020-01-01)

Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers
by: Bo Yang, et al.
Published: (2018-11-01)

Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?
by: Cinzia Solinas, et al.
Published: (2021-04-01)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
by: Junyu Long, et al.
Published: (2017-08-01)

PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
by: Jian-ye Zhang, et al.
Published: (2020-05-01)

Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
by: Panagiotis Balermpas, et al.
Published: (2017-03-01)

Construction of plasmids expressing recombinant B cell epitopes of PD1
by: Sofy Meilany, et al.
Published: (2019-07-01)

Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series
by: Liliana Fernández-Trujillo, et al.
Published: (2020-01-01)

Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy
by: Fengling Wang, et al.
Published: (2021-03-01)